Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

PILL Insider Trading

PILL | Market Equity

Comprehensive Trading Performance Summary

The investment history of corporate insiders at PILL provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.

Last 7 Days
$0
Buys
$0
Sells
Last 30 Days Trend
$0
Buys
$0
Sells

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2008-07-28 14:37 2008-07-23 Rajaratnam Raj 10% owner SELL $0.13 277,000 $36,232 716,214 -27.9%
2008-07-26 03:32 2008-05-23 Rajaratnam Raj 10% owner SELL $0.13 277,000 $36,232 716,214 -27.9%
2008-05-07 22:59 2008-05-07 GALLEON HEALTHCARE OFFSHORE LTD 10% owner BUY $1.50 50,000 $75,000 2,013,314 +2.5%
2007-12-28 01:27 2007-12-27 GALLEON HEALTHCARE OFFSHORE LTD 10% owner BUY $2.30 19,250 $44,275 2,049,964 +0.9%
2007-12-26 23:22 2007-12-21 GALLEON HEALTHCARE OFFSHORE LTD 10% owner BUY $1.80 73,902 $133,349 2,030,714 +3.8%
2007-08-16 23:57 2007-08-15 GALLEON HEALTHCARE OFFSHORE LTD 10% owner BUY $3.51 508,646 $1,783,262 1,956,812 +35.1%
2007-03-20 16:15 2007-03-19 Hudak James B Director BUY $2.95 24,200 $71,388 49,200 +96.8%
2007-03-19 21:49 2007-03-19 Pietrzak Emily J Officer - EVP BUY $2.96 500 $1,482 1,000 +100.0%
2007-03-19 20:12 2007-03-16 Pietrzak Emily J Officer - EVP BUY $2.97 500 $1,484 500 +100.0%
2007-03-19 19:28 2007-03-16 Lettko John G Director, Officer - Chief Executive Officer BUY $2.99 10,000 $29,895 87,520 +12.9%
2006-12-22 00:30 2006-12-21 Hudak James B Director BUY $4.47 4,396 $19,658 20,000 +28.2%
2006-12-21 17:09 2006-12-20 Hudak James B Director BUY $4.50 5,000 $22,500 15,604 +47.2%
2006-12-16 01:51 2006-12-15 Hudak James B Director BUY $4.50 4,000 $18,000 10,604 +60.6%
2006-11-17 23:42 2006-11-17 SCHWARTZ SAMUEL R Director BUY $4.20 19,700 $82,730 19,700 +100.0%
2004-11-29 23:45 2004-11-29 SCHMID JUDSON E Officer - EVP & Chief Accounting Officer SELL $0.00 1,186 $0 0 -100.0%
2004-08-24 20:43 2004-08-24 HOOVER MICHAEL K Director, Officer - Chairman and CEO BUY $9.50 1,000 $9,500 138,278 +0.7%
2004-08-19 16:15 2004-08-18 HOOVER MICHAEL K Director, Officer - Chairman & CEO BUY $9.75 1,000 $9,750 137,278 +0.7%
2004-08-17 21:05 2004-08-13 HOOVER MICHAEL K Director, Officer - Chairman and CEO BUY $0.00 3,189 $0 136,278 +2.4%
2004-08-16 22:30 2004-08-16 HOOVER MICHAEL K Director, Officer - Chairman and CEO BUY $0.00 2,500 $0 135,589 +1.9%
2004-08-16 21:42 2004-08-13 OLES DAVID E Officer - VP, Sr Corp Counsel & Secretar BUY $10.60 50 $530 50 +100.0%
2004-03-11 21:42 2004-03-11 HAM NANCY Officer - President and COO BUY $16.87 500 $8,435 4,583 +12.2%
2004-03-10 21:38 2004-03-02 FALK MICHAEL Director, 10% owner BUY $2,148,779.19 287,719 $618,244,599,998 175,438 +100.0%
2004-03-04 22:44 2004-03-02 KELLY BRADEN R Director BUY $14.25 1,261,846 $17,981,306 2,828,641 +80.5%
2004-03-04 22:42 2004-03-02 GAPSTAR LLC 10% owner BUY $14.25 15,789 $224,993 117,622 +15.5%
2004-03-04 22:40 2004-03-02 GENERAL ATLANTIC PARTNERS LLC 10% owner BUY $14.25 1,181,973 $16,843,115 2,573,627 +84.9%
2004-03-04 22:38 2004-03-02 GAPCO GMBH & CO KG 10% owner BUY $14.25 1,311 $18,682 3,882 +51.0%
2004-03-04 22:35 2004-03-02 GAPCO MANAGEMENT GMBH 10% owner BUY $14.25 1,311 $18,682 3,882 +51.0%
2003-08-14 16:37 2003-08-13 HARDY A THOMAS Officer - Sr. V.P., Laboratory Services BUY $14.19 300 $4,257 48,942 +0.6%
SHOW ENTRIES
1-28 OF 28

How to Interpret $PILL Trades

Not every insider transaction in PILL is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $PILL shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for PILL

Insider activity data for PILL is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $PILL, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.